Objectives: In resource-poor settings, the standard of care to inform labour management is the partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the Pinard as a primary screening tool for abnormal FHR on perinatal outcomes. Design: Prospective equally randomised clinical trial. Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following uncomplicated pregnancies, were randomised to either the standard of care or not. Intervention: Intermittent FHR monitoring using Doppler. Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and neonatal mortality prior to discharge. Results: Age, parity, gestational age, mode of delivery and newborn weight were similar between study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities detected (incidence rate ratio (IRR)=1.61, 95% CI 1.13 to 2.30). However, in this group, there were also higher though not statistically significant rates of intrapartum stillbirths (IRR=3.94, 0.44 to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34). Conclusions: Routine monitoring with a handheld Doppler increased the identification of FHR abnormalities in labour; however, our trial did not find evidence that this leads to a decrease in the incidence of intrapartum stillbirth or neonatal death.
We undertook this randomised controlled trial at St. Raphael of St. Francis Nsambya Hospital, a periurban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that manages 7500 deliveries annually. CTG and fetal blood gas sampling to support labour management, and epidural pain medication are not available. Oxytocin augmentation and caesarean delivery rates are 40% and 20%, respectively. The standard of care for intrapartum FHR monitoring is by intermittent auscultation using the Pinard. Women were requested to participate during an antenatal care appointment. This consent was reconfirmed in labour provided the women presented in labour with a singleton pregnancy, in a cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were already in second stage of labour on admission or presented with a condition that, according to the doctor on duty, contraindicated labouring (eg, antepartum haemorrhage); if there was a diagnosis of intrauterine fetal death on admission; or if the woman was admitted for an elective caesarean delivery. Participants were presented with information about the study and agreeing participants provided written consent. Registration of our protocol with ClinicalTrials.gov occurred before participant enrolment started, but due to an administrative error with our institution’s Clinical Research Services Unit, the protocol was only released to the public after the completion of the study. Documentation from the Chair of our independent Research Ethics Board was provided to BMJ Open attesting to the version of the protocol provided to them prior to the start of enrolment. Women were equally randomised to one of the two study methods using sequentially numbered, opaque sealed envelopes. Study participants and care providers were not blinded to the intervention. Data were collected from the patient’s partograph and from the hospital’s routine neonatal mortality audit data, when applicable. The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with the Pinard. Our prestudy training addresses deficiencies in monitoring standards (acceptable range for FHR, recognition of accelerations, decelerations and change in baseline). We developed a training module entitled ‘Helping Babies Survive Labour’ modelling on the ‘Helping Babies Breathe’ visual materials and learning approach. The technical basis was from WHO and Canadian Obstetric Society protocols.5 All midwives and doctors were then given this in-service training for half a day. FHR monitoring was undertaken every 30 min in the first stage of labour; every 15 min in the second stage before pushing; and every 5 min in the second stage when pushing and for 1 min immediately after a contraction. The baseline FHR was recorded as a single number rather than a range, in the unit of bpm. The FHR rhythm (regular or irregular) and absence or presence of accelerations or decelerations were also documented. The maternal radial pulse was simultaneously palpated to differentiate it from the FHR. When FHR abnormalities were identified, the standard of care would be to switch from intermittent auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR abnormalities were reported by the research midwife to the doctor on duty for assessment. Management following this assessment was either closer intermittent monitoring or intrauterine resuscitation with reassessment of the FHR. Intrauterine resuscitation consisted of maternal position change, administration of oxygen by mask to the mother-to-be, initiation of intravenous infusion, discontinuation of oxytocin augmentation and consideration of prompt delivery (assisted vaginal if imminent, otherwise by caesarean). The primary outcome measures of interest were detection of FHR abnormality in labour (defined below), intrapartum stillbirth and neonatal deaths in the first 24 h of life. FHR abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged decelerations. Tachycardia and bradycardia are defined as baselines of >160 and 2 min, slow return to baseline, or in the presence of tachycardia. Late decelerations are a repetitive, gradual decrease in the FHR and return to baseline, starting after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged decelerations are a decrease from baseline of >15 bpm lasting for 2–10 min. Secondary outcomes were Apgar score less than 7 at 5 min, admission to special care unit for intrapartum-related complications (intrapartum hypoxia, neonatal encephalopathy (NE) or meconium aspiration syndrome), diagnosis of NE and delivery by caesarean. A validated and simplified scoring method was used for grading mild, moderate and severe NE.15 16 Indications for caesarean delivery were failure to progress (as indicated by crossing of the action line on the partograph), abnormal FHR unresponsive to uterine resuscitation and identification of malpresentation in labour (eg, conversion from vertex to brow or mentum posterior). Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared with the Pinard (based on the results of Mahomed et al14), with 80% power to detect at least a 30% reduction in stillbirths with 95% confidence, we would need to enrol 840 participants in each of the two comparison groups. We added 20% to the sample size for each study arm to account for loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants required for each comparison group. Data were double entered from the partograph and, where applicable, the hospital’s routine neonatal mortality audit document. An interim analysis was conducted by the data safety and monitoring board at the midpoint of the data collection period. Descriptive statistics were used to describe the characteristics of the participants and their outcomes under each study arm. We used population-averaged generalised Poisson regression modelling with robust variance to compare methods of FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of detection of FHR abnormalities, intrapartum stillbirth and neonatal mortality (see Barros and Hirakata17 for details of this choice over logistic regression). We conducted a subgroup analysis and qualitative reporting on the intrapartum stillbirths and pre-discharge neonatal deaths within 24 h and those fetuses with detected abnormal FHR. All analyses were conducted using Stata/SE (StataCorp, 2011. Stata Statistical Software: Release V.12. College Station, Texas, USA: StataCorp LP). The sponsor had no role in designing the study, analysing data, collecting data, interpreting the results, writing the report or in the decision to submit the paper for publication. The corresponding author had complete access to all the data.